Key facts
- This page summarizes Stephen L. Eck's Form 4 filing for MACROGENICS INC (MGNX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 20 Feb 2024, 18:41.
Stephen L. Eck - 15 Feb 2024 Form 4 Insider Report for MACROGENICS INC (MGNX)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- MGNX
- Reported as of
- 15 Feb 2024
- Net transaction value
- -$119,573
- SEC form
- 4
- Accepted by SEC
- 20 Feb 2024, 18:41:46 UTC
- Prior SEC filing
- 12 Feb 2024
- Next SEC filing
- 11 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lynn M. Cilinski, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Stephen L. Eck filed Form 4 for MACROGENICS INC (MGNX) on 20 Feb 2024.
Change
- Previous filing in this sequence was filed on 12 Feb 2024.
- Current net transaction value: -$119,573.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MGNX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +16,670
- Change %
- Price
- $0.000000
- Shares after
- 16,670
- Date
- 15 Feb 2024
- Ownership
- Direct
- Footnotes
- F1
MGNX
transaction
Common Stock
Tax liability
- Transaction value
- $119,573
- Shares
- -6,872
- Change %
- -41%
- Price
- $17.40
- Shares after
- 9,798
- Date
- 15 Feb 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MGNX
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -16,670
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 33,330
- Date
- 15 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 16,670
- Exercise price
- $0.000000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
On February 15, 2023 the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.